If you bill for workers’ compensation claims in California, July 1, 2026, brought a fee schedule update you need to know about The California Division of Workers’ Compensation published a third-quarter change to the Physician and Non-Physician Practitioner Fee Schedule, which includes reimbursement for 79 new codes and a new calculation formula for 30 existing codes. If you are already managing dozens of rules with your payers, it’s another moving part that can quietly impact your bottom line if it’s overlooked.
Here’s the full breakdown of what changed, why it matters, and what your practice should do next.
California Division of Workers’ Compensation Fee Schedule Update: Why It Changed?
California law requires its workers’ comp Physician Fee Schedule to track updates made to Medicare’s payment system. When Medicare adds codes, removes codes, or changes codes, the Division of Workers’ Compensation’s workers’ compensation Fee Schedule must follow suit pursuant to Labor Code Section 5307.1. This quarter’s update was confirmed to the Newsline and adopted on the DWC’s web page for dates of service 7/1/2026 and later.
In plain terms: this is a routine, legally mandated sync-up, not a sign of policy upheaval. However, there is a difference between “routine” and “ignorable.” These changes are missed quarterly by busy practices, and unbilled codes become lost revenue.
79 New HCPCS Codes Added to the Workers’ Comp Fee Schedule: Detailed Codes
Every one of these 79 codes is reimbursed on a “By Report” basis. This means that no dollar amount is attached to that. Instead, per California Code of Regulations Section 9789.12.4, the provider identifies a comparable procedure, one requiring similar time, skill, and resources, and bills accordingly, with documentation to support the comparison.
|
HCPCS |
Modifier | Description |
Reimbursement |
|
90616 |
Tirv vacc mrna 37.5/0.38 im | By Report | |
|
90639 |
Vacc qirv mrna 50mcg/.5ml im |
By Report |
|
|
1026T |
Trvg lsr photobiom ther plvs | By Report | |
| 1027T | Prq ins/rplc nstm cth vnt pt |
By Report |
|
|
1028T |
Map&prgr nstm cth vent repos | By Report | |
| 1029T | Map&prg nstm cth vnt wo rpos |
By Report |
|
|
1030T |
Crtj dig 3d mdl surf mesh 1 | By Report | |
| 1031T | Crtj dig 3d mdl surf mesh ea |
By Report |
|
|
1032T |
Crtj dig 3d mdl mesh&sim 1 | By Report | |
| 1033T | Crtj dig 3d mdl mesh&sim ea |
By Report |
|
|
1034T |
Crt dig 3d mdl msh sim&aly 1 | By Report | |
| 1035T | Crt dig 3dmdl msh sim&aly ea |
By Report |
|
|
1036T |
N-invas hemodyn asmt plm prs | By Report | |
| 1036T | 26 | N-invas hemodyn asmt plm prs |
By Report |
|
1036T |
TC | N-invas hemodyn asmt plm prs | By Report |
| 1037T | Histotripsy mal pncrtc tiss |
By Report |
|
|
1038T |
Autol musc cll ther njx tong | By Report | |
| 1039T | Connectomic alys prv brn mri |
By Report |
|
|
1039T |
26 | Connectomic alys prv brn mri | By Report |
| 1039T | TC | Connectomic alys prv brn mri |
By Report |
|
1040T |
Brnchsc flx brncl crtx 1 lng | By Report | |
| 1041T | Augmnt alg alys enceph wvfrm |
By Report |
|
|
1041T |
26 | Augmnt alg alys enceph wvfrm | By Report |
| 1041T | TC | Augmnt alg alys enceph wvfrm |
By Report |
|
1042T |
Impl absrb uro scaff prstatc | By Report | |
| 1043T | Quan mr alys liver tiss 1/+ |
By Report |
|
|
1043T |
26 | Quan mr alys liver tiss 1/+ | By Report |
| 1043T | TC | Quan mr alys liver tiss 1/+ |
By Report |
|
1044T |
Hrv fth autol htro skn grf 1 | By Report | |
| 1045T | Hrv fth autl htro skn grf ea |
By Report |
|
|
1046T |
Autol htro grf appl t/a/l 1 | By Report | |
| 1047T | Autol htro grf appl t/a/l ea |
By Report |
|
|
1048T |
Autol htro grf appl f-dgt 1 | By Report | |
| 1049T | Autol htro grf appl f-dgt ea |
By Report |
|
|
1050T |
Ins subq hrt fail dcomp mntr | By Report | |
| 1051T | Rmv subq hrt fail dcomp mntr |
By Report |
|
|
1052T |
Interg sbq hrt fail dcm mntr | By Report | |
| 1052T | 26 | Interg sbq hrt fail dcm mntr |
By Report |
|
1052T |
TC | Interg sbq hrt fail dcm mntr | By Report |
| 1053T | Prgrmg sbq hrt fail dcm mntr |
By Report |
|
|
1053T |
26 | Prgrmg sbq hrt fail dcm mntr | By Report |
| 1053T | TC | Prgrmg sbq hrt fail dcm mntr |
By Report |
|
A9574 |
Inj. ferumoxytol, 1 mg | By Report | |
| G0574 | Mgt new pt dem res care cmmi |
By Report |
|
|
G0575 |
Mgt est pt dem res care cmmi | By Report | |
| G0577 | Vasc emb/occl organ, pgc |
By Report |
|
|
G0669 |
Eckm oap-initial period | By Report | |
| G0670 | Eckm oap-follow-on period(s) |
By Report |
|
|
G0671 |
Ckm oap-initial period | By Report | |
| G0672 | Ckm oap-follow-on period(s) |
By Report |
|
|
G0673 |
Msk oap-initial period | By Report | |
| G0674 | Bh oap-initial period |
By Report |
|
|
G0675 |
Bh oap-follow-on period(s) | By Report | |
| G0676 | Std co-mgmt-eckm, ckm |
By Report |
|
|
G0677 |
Std co-mgmt-msk | By Report | |
| G0678 | Std co-mgmt-bh |
By Report |
|
|
J0528 |
Inj fosfomycin disodium 20mg | By Report | |
| J1289 | Narsoplimab-wuug, 1 mg |
By Report |
|
|
J1577 |
Inj, qivigy, 100mg | By Report | |
| J2361 | Inj depemokimab-ulaa 1 mg |
By Report |
|
|
J2374 |
Apraclonidine hcl opht 0.1ml | By Report | |
| J2789 | Riboflavin epioxa/hd<=2ml |
By Report |
|
|
J3386 |
Etuvetidigene autotemecel | By Report | |
| J3405 | Inj onase abepar-brve treat |
By Report |
|
|
J7176 |
Inj. fesilty, 1 mg | By Report | |
| J9053 | Inj belantamab mafodot blmf |
By Report |
|
|
J9062 |
Inj amivantamab 5mg hyaluron | By Report | |
| J9232 | Inj docetaxel (hospira) 1 mg |
By Report |
|
|
M0231 |
Inf tocilizumab-bavi 1st dos | By Report | |
| M0232 | Inf tocilizumab-bavi 2nd dos |
By Report |
|
|
Q0234 |
Inj, tocilizumab-bavi, 1mg | By Report | |
| Q5164 | Ustekinumab-hmny, 1 mg |
By Report |
|
|
Q5165 |
Inj, denosumab-mobz, 1 mg |
By Report |
|
|
Q5166 |
Inj, denosumab-desu, 1 mg | By Report | |
| Q5167 | Inj, denosumab-qbde, 1 mg |
By Report |
|
|
Q5168 |
Inj. nufymco, 0.1 mg | By Report | |
| Q5169 | Inj, armlupeg, 0.5 mg |
By Report |
|
|
Q5170 |
Inj, aflibercept-boav, 1 mg | By Report | |
| Q5171 | Inj, den (boncres), bio, 1mg |
By Report |
Broadly, these 79 additions span Category III technology codes (T-codes for emerging diagnostic and therapeutic procedures), new G-codes for chronic disease and behavioral health co-management programs, and a large wave of J-codes and Q-codes covering newly reimbursable injectable drugs and biosimilars.
30 HCPCS Codes with Updated Reimbursement Calculations Under the Workers’ Comp Fee Schedule
The second half of the update affects 30 HCPCS codes already on the fee schedule. Of these, only one — A4100 — is fee-affecting. The remaining 29 received a new Status Indicator (the classification used to determine reimbursement eligibility), but the actual payment amount is unchanged for those 29.
|
HCPCS |
Description | Calculation Before July 1 | Calculation On/After July 1 | Status Before | Status After | Fee-Affecting? |
| A4100 | Nosht skin sub fda clrd nos | RVU+GPCI+CF | By Report | A | C |
Yes |
|
Q4112 |
Cymetra injectable | By Report | By Report | E | C | No |
| Q4113 | Graftjacket xpress | By Report | By Report | E | C |
No |
|
Q4114 |
Integra flowable wound matri | By Report | By Report | E | C | No |
| Q4118 | Matristem micromatrix | By Report | By Report | E | C |
No |
|
Q4139 |
Amnio or biodmatrix, inj 1cc | By Report | By Report | E | C | No |
| Q4145 | Epifix, inj, 1mg | By Report | By Report | E | C |
No |
|
Q4149 |
Excellagen, 0.1 cc | By Report | By Report | E | C | No |
| Q4155 | Neoxflo or clarixflo 1 mg | By Report | By Report | E | C |
No |
|
Q4162 |
Wndex flw, bioskn flw, 0.5cc | By Report | By Report | E | C | No |
| Q4168 | Amnioband, 1 mg | By Report | By Report | E | C |
No |
|
Q4171 |
Interfyl, 1 mg | By Report | By Report | E | C | No |
| Q4174 | Palingen or promatrx | By Report | By Report | E | C |
No |
|
Q4177 |
Floweramnioflo, 0.1 cc | By Report | By Report | E | C | No |
| Q4185 | Cellesta flowab amnion 0.5cc | By Report | By Report | E | C |
No |
|
Q4189 |
Artacent ac, 1 mg | By Report | By Report | E | C | No |
| Q4192 | Restorigin, 1 cc | By Report | By Report | E | C |
No |
|
Q4202 |
Keroxx (2.5g/cc), 1cc | By Report | By Report | E | C | No |
| Q4206 | Fluid flow or fluid gf 1 cc | By Report | By Report | E | C |
No |
|
Q4212 |
Allogen, per cc | By Report | By Report | E | C | No |
| Q4213 | Ascent, 0.5 mg | By Report | By Report | E | C |
No |
|
Q4215 |
Axolotl ambient, cryo 0.1 mg | By Report | By Report | E | C | No |
| Q4230 | Cogenex flow amnion 0.5 cc | By Report | By Report | E | C |
No |
|
Q4233 |
Surfactor /nudyn per 0.5 cc | By Report | By Report | E | C | No |
|
Q4240 |
Corecyte topical only 0.5 cc | By Report | By Report | E | C |
No |
| Q4241 | Polycyte, topical only 0.5cc | By Report | By Report | E | C |
No |
|
Q4242 |
Amniocyte plus, per 0.5 cc | By Report | By Report | E | C | No |
| Q4245 | Amniotext, per cc | By Report | By Report | E | C |
No |
|
Q4246 |
Coretext or protext, per cc | By Report | By Report | E | C | No |
| Q4310 | Procenta, per 100 mg | By Report | By Report | E | C |
No |
Notice that most of these 30 codes are skin substitute and wound matrix products (the Q41xx and Q42xx ranges). This reflects Medicare’s broader effort to standardize how skin substitutes are classified and paid, and California’s Fee Schedule for workers’ compensation is simply following that lead.
How This Fee Schedule Update Affects Workers Compensation Billing for Providers
Here’s the reassurance worth repeating: patients won’t suddenly receive different treatment authorizations because of this update. It’s mainly an administrative reimbursement change. Authorized care continues as planned, what shifts is how certain codes are billed and reimbursed on the back end.
That said, “administrative” doesn’t mean “harmless to ignore.” A missed Status Indicator update or an incorrectly calculated By Report claim can lead to denials, underpayment, or time-consuming appeals. For any workers compensation billing companies or in-house billing teams managing high claim volumes, quarterly fee schedule reviews should be a standing part of the workflow, not an afterthought triggered by a denied claim.
A few practical steps for practices handling billing for workers compensation claims in California:
- Update your billing software or clearinghouse mapping to reflect the 79 newly reimbursable codes
- Flag the 30 updated codes internally, with special attention to HCPCS A4100 since it’s the only fee-affecting change
- Train billing staff on By Report documentation standards, since all 79 new codes fall under this reimbursement method
- Audit claims submitted on or after July 1, 2026 to confirm the correct rates and status codes were applied
- Coordinate with your EHR or practice management vendor to confirm their code libraries are current
This is just the type of information that can make the difference between a practice that is paid the first time it sends the claims in correctly and a practice that keeps resubmitting the claim for months.
For specialty practices such as a chiropractic practice with a heavy workload of workers’ comp cases the stakes are even higher because chiropractic medical billing services are likely to have to process a variety of treatment codes that are particularly vulnerable to fee schedule and status updates.
Why Practices Rely on Workers’ Compensation Billing Services to Stay Compliant?
Staying on top of quarterly DWC updates, Medicare crosswalks, and documentation rules already takes a lot of effort for a billing department — and that’s without any of the other tasks they have to deal with: eligibility checks, prior authorizations, denial management and A/R follow-up. That’s why many practices choose to work with experienced USA medical billing companies who specialize in workers’ comp claims and keep up to date on all fee schedule changes as they are published.
At Doctor Management Services, our team monitors every California DWC update as it’s released, so our clients never have to manually track HCPCS additions, Status Indicator changes, or By Report calculation rules. If you’re using a dedicated workers compensation billing service for a specific specialty or a multi-provider group, our Workers Comp billing specialists implement these changes as soon as they are implemented, minimizing denials and keeping your reimbursement process on track.
Key Takeaways: California Workers’ Comp Fee Schedule Q3 2026
- Effective July 1, 2026, California added 79 new reimbursable HCPCS codes to its workers’ comp Fee Schedule, all billed “By Report”
- 30 existing codes had reimbursement calculation or status changes, but only HCPCS A4100 is fee-affecting
- The update aligns with Medicare changes as required under Labor Code Section 5307.1
- Treatment authorizations for injured workers are unaffected, this is a billing and reimbursement update, not a change in care access
- Practices should update coding systems, retrain staff on By Report documentation, and audit recent claims to avoid denials
Final Thoughts
As with fee schedules, changes to this one can be easy to miss unless an insurance claim gets rejected. The key difference between code library smoothness and months of rework is staying proactive by checking your code library, training staff, and working with billing professionals that know how to track these changes in real time.



